Chronic inflammation underlies various neural and retinal degenerative diseases such as age-related macular degeneration (AMD), the leading cause of blindness in industrialized countries. 1 AMD is a slowly progressive disease characterized by extracellular deposits formed beneath the retinal pigment epithelium (RPE) (called drusen), degeneration of the RPE and photoreceptors, the subsequent development of geographic atrophy and/or choroidal neovascularization, along with the accumulation of inflammatory cells in the macula. 2, 3 Drusen contains several pro-inflammatory components such as complement proteins, lipoproteins, oxidized lipids and double-stranded RNA (dsRNA). 4, 5 Moreover, identification of genetic variations in inflammation-related genes, such as complement genes, implicates inflammation as a potential factor in AMD. 6 However, the key factors that promote inflammation in AMD and the intimate relationship between retinal inflammation and cell death remain elusive.
Inflammation is an important pathological feature of necrosis. 7 Damage-associated molecular patterns (DAMPs) released from necrotic cells enhance the inflammatory response and tissue injury. 8, 9 Although necrosis was thought to be an uncontrolled process of cell death, it is now known to proceed through regulated components in certain instances. 10 Receptor-interacting protein 3 (RIP3) is a key mediator of programmed necrosis induced through death receptors or toll-like receptors (TLRs). 11 During necrosis induction, RIP3 interacts with RIP1 to form a pro-necrotic complex, which is stabilized by phosphorylation of their serine/ threonine kinase domains. [12] [13] [14] This pathway is critically important in development and in many pathological processes. [15] [16] [17] Notably, Rip3 deficiency not only prevents necrosis but also ameliorates inflammation in models of colitis, sepsis, retinal detachment and inherited retinal degeneration. [18] [19] [20] [21] However, the mechanisms by which RIP3 regulates inflammation have not been fully explored.
The dsRNA component of drusen is a ligand for TLR3 that mediates innate immune response and cell death. Whereas RIP1 acts as a multifunctional adaptor protein that regulates NF-kB-dependent inflammation, apoptosis and necrosis in TLR3 signaling, RIP3 has a more specific role, which induces necrosis through the formation of the pro-necrotic complex. 22, 23 Although previous studies have shown that intraocular injection of polyinosinic-polycytidylic acid (poly(I : C)), a synthetic analog of dsRNA, induces TLR3-dependent retinal degeneration, 24, 25 the downstream molecular and biological events were not elucidated. In this study, we examined the mechanism of cell death of RPE and photoreceptors in dsRNA-induced retinal degeneration and identified programmed necrosis to promote inflammation by regulating the release of intracellular DAMPs and to be crucial in dsRNA-induced retinal degeneration. These findings suggest that the RIP kinase-dependent necrotic pathway is a potential target to prevent retinal inflammation and degeneration associated with dsRNA accumulation.
Result RIP3-mediated necrosis, rather than apoptosis, is the major mediator of dsRNA-induced retinal degeneration in mice. To analyze the types of cell death involved in dsRNA-induced retinal degeneration, we investigated the morphology of the RPE and photoreceptors by transmission electron microscopy (TEM). Two days after poly(I : C) injection, the dying RPE cells exhibited necrotic morphology accompanied by swollen cytoplasmic vacuoles in wild-type (WT) mice (Figure 1a) . No apoptotic RPE cells with cellular shrinkage or nuclear condensation were observed. On the other hand, the outer nuclear layer (ONL) of photoreceptors exhibited the presence of both apoptotic and necrotic nuclei after poly(I : C) injection (Figure 1b) . The occurrence of photoreceptor necrosis was further supported by the finding of swollen vacuoles and disrupted mitochondria in the inner segments (Figure 1c ). In contrast, features of necrosis in RPE and photoreceptors after poly(I : C) injection were markedly notably absent in Rip3-deficient animals (Figures 1d-f ).
To further examine the role of necrosis in dsRNA-induced retinal degeneration, we examined the expression levels of RIP3, which is markedly upregulated during the induction of necrosis in pancreatitis, enteritis and retinal degeneration. 13, 20, 21, 26 Subretinal injection of PBS did not affect the expression levels of RIP3 compared with untreated retinas in WT mice (Supplementary Figure S1) . In contrast, subretinal injection of poly(I : C) increased retinal RIP3 expression over five-fold at both mRNA and protein levels (Po0.05, Figures 2a and b) .
We next evaluated the effect of Rip3 deficiency on poly(I : C)-induced retinal degeneration. TUNEL staining, which labels DNA breaks in both necrotic and apoptotic cells, showed that poly(I : C) treatment induced a substantial increase in TUNEL-positive cells mainly in the ONL of the WT mouse retinas 2 days after injection (Figures 2c and d) . This increase in TUNEL-positive cells was significantly reduced in Rip3-deficient animals (Po0.05, Figures 2c and d) .
We also assessed the involvement of the caspasedependent apoptotic pathway in poly(I : C)-induced retinal degeneration. Cleavage of caspase-3, a key effector caspase, was observed 2 days after poly(I : C) injection; however, the frequency of cleaved caspase-3-positive cells was much lower than that of TUNEL-positive cells (Supplementary Figure S2 Collectively, these data indicate that RIP3-dependent necrosis has a critical role in dsRNA-induced retinal degeneration.
RIP3 promotes a retinal inflammatory response after dsRNA injection in mice. We next assessed the effect of subretinal poly(I : C) injection on the inflammatory response in Rip3
À / À mice. Immunostaining for CD11b demonstrated a robust macrophage infiltration around the RPE and in the subretinal space 2 days after poly(I : C) injection in WT mice (Figures 3a and b) . In contrast, the macrophage infiltration was significantly reduced in Rip3 À / À mice (Po0.01, Figures 3a and b) . Correspondingly, treatment with Nec-1 also suppressed macrophage infiltration after poly(I : C) injection (Po0.05, Supplementary Figure S4 ). In contrast, Z-VAD treatment did not affect the recruitment of inflammatory cells induced by poly(I : C) (Supplementary Figure S4) . We also examined the inner retinal inflammation by whole-mount staining for the microglial marker Iba-1. In WT mice, the number of microglial cells around the ganglion cell layer (GCL) was substantially increased 2 days after poly(I : C) injection (Supplementary Figure S5) . In contrast, the microglial activation after poly(I : C) treatment was relatively decreased in Rip3
We next evaluated the expression levels of pro-inflammatory cytokines in mouse retinas after poly(I : C) injection. The protein levels of TNF-a and IL-6 were elevated at 6 h and further increased at 48 h after poly(I : C) injection in WT mice (Figures 3c and d) . Whereas the early induction of TNF-a and IL-6 at 6 h did not differ between Rip3
À / À and WT mice, their levels at 48 h were substantially decreased in Rip3 Figures 3c and d) .
Dying or damaged cells release DAMPs that activate immune responses via interaction with cellular receptors such as TLRs. 7 As high-mobility group box 1(HMGB1) is a major DAMP released from necrotic cells, 27 we examined the changes in HMGB1 release after poly(I : C) treatment. Subretinal injection of poly(I : C) induced HMGB1 release into the vitreous humor of WT mice at 48 h after poly(I : C) injection. In contrast, this poly(I : C)-induced HMGB1 release was significantly impaired in Rip3 À / À mice compared with WT mice (Po0.01, Figure 3e ). These findings suggest that RIP3 may regulate the inflammatory responses in dsRNA-induced retinal degeneration and dampen the release of intracellular DAMPs.
RIP3-dependent necrosis releases DAMP and the necrotic supernatants enhance cytokine production from macrophages. We next examined the function of RIP3 in necrosis induction and cytokine production using primary RPE cells and macrophages derived from WT or Rip3 À / À mice. A previous study showed that poly(I : C) combined with a pan-caspase inhibitor causes massive programmed necrosis in macrophages. 28 Consistent with this, RPE cells treated with poly(I : C) and Z-VAD showed substantial reduction in cellular viability, which was completely reversed in Rip3 À / À RPE cells (Figure 4a ). In addition, treatment with poly(I : C) and Z-VAD induced a substantial release of HMGB1 from WT RPE cells into the supernatant (Figure 4b ). In contrast, this HMGB1 release induced by poly(I : C) and Z-VAD was completely prevented in Rip3
To further analyze the ability of DAMPs to promote inflammation, we incubated macrophages with the supernatant from normal or necrotic RPE cells. Whereas the addition of supernatants from RPE cells treated with poly(I:C) alone did not increase TNF-a and IL-6 production levels in macrophages compared with those from control RPE cells, the supernatant from necrotic RPE cells treated with poly(I : C) and Z-VAD substantially increased TNF-a and IL-6 production levels (Figures 4c and d) . In contrast, the supernatants from Rip3-deficient RPE cells with either treatment did not enhance cytokine production (Figures 4c and d) , suggesting that DAMPs released from necrotic cells are important for the amplification of the inflammatory response.
We next investigated whether RIP3 directly modulates NF-kB signaling and cytokine production in primary RPE cells and macrophages. Newton et al. 29 previously reported that Rip3-deficient cells show normal NF-kB signaling in response Figures S6 and S7) . Furthermore, Rip3-deficient cells produced equivalent levels of TNF-a and IL-6 in WT cells after treatment with poly(I : C) or TNF-a ( Supplementary Figures S6 and S7 ). These findings imply that RIP3 may not directly modulate inflammatory cytokine release induced by dsRNA.
Discussion
In the present study, we demonstrated that RIP3 has a critical role in inducing necrosis of the RPE and photoreceptors, as well as in sustaining retinal inflammation during dsRNAinduced retinal degeneration.
Our study showed that RPE cells die mainly by necrosis, not by apoptosis, during dsRNA-induced retinal degeneration. In contrast, photoreceptor cell death exhibited both necrotic and apoptotic features. Whereas caspase inhibitors had little protective effect in this model, RIPK inhibitors, or combined caspase and RIPK inhibitors, had significant amelioration of the pathology observed. In other models of RPE degeneration such as mice immunized with carboxyethylpyrrole-adducted mouse serum albumin and ApoE À / À mice fed with cholesterol-enriched diet, the RPE cells exhibit vesiculation and swelling rather than pyknosis, 30, 31 consistent with necrotic cell death. Although the cell death pathways in slowly progressive human AMD have not been fully characterized, histological studies demonstrated that the budding portion of the RPE into the drusen exhibits disintegration and disruption of the plasma membrane. 32 In addition, RPE cells overlying drusen show necrotic changes such as cellular enlargement and vacuole formation in early AMD patients. 33, 34 These findings suggest that necrotic pathways may be crucial in RPE cell death in AMD. Interestingly, Yang et al. 35 reported that caspase activation is decreased in RPE cells that express low levels of caspase-8. As catalytic activity of caspase-8 inhibits the formation of the RIP1-RIP3 complex, 16 the reduced caspase-8 expression may predispose RPE cells to undergo necrosis.
In AMD, rod photoreceptor cells in the parafovea degenerate first before the foveal cones die. 36 Shelley et al.
37
reported that the dying cones in AMD patient eyes showed an axonal enlargement and swelling, consistent with necrosis. In addition, in vivo imaging of the fovea in patients with geographic atrophy exhibited widening and swelling of the foveal structure, 38 suggesting that necrotic signaling may be involved in photoreceptor cell death in AMD, especially in cone-cell loss. Interestingly, our recent study demonstrated that the secondary cone-cell death after rod degeneration in a Although the causes and clinical characteristics of AMD and retinitis pigmentosa differ, these findings suggest that the mechanisms underlying the secondary cone necrosis may be shared by these diseases. RIP kinase is activated downstream of the TNF/Fas family of death ligands as well as dsRNA. Our recent genetic study has identified a susceptibility locus for neovascular AMD, which is located 397 bp upstream of the TNF-related apoptosis-inducing ligand receptor 1. 39 In addition, Li et al. 40 recently showed that the RIP1-RIP3 complex forms an amyloid structure -a component of drusen seen in AMD patients. These findings suggest the possible involvement of RIP kinase in AMD pathology, and further studies are necessary to clarify the roles of RIP kinase in cell death and inflammation in AMD.
Reduced inflammatory response in Rip3 À / À mice has also been demonstrated in models of sepsis, colitis and viral infection; 12, 18, 19 however, the precise mechanisms by which RIP3 mediates inflammation remain to be elucidated. Here, we showed that Rip3 deficiency suppressed the DAMP release from necrotic cells and the cytokine production evoked by necrotic byproducts. In contrast, in line with a previous study by Newton et al., 29 neither the production of TNF-a and IL-6 nor the NF-kB activation in response to poly(I : C) was altered in primary RPE cells and macrophages of Rip3 À / À mice. Collectively, these findings suggest that RIP3 may not directly modulate cytokine production or inflammatory cell function, but rather suggest that RIP3-induced necrosis of the RPE and photoreceptors enhances retinal inflammation. TLR3 has been implicated in various pathological conditions including viral infection, sepsis and retinal degeneration. 8, 25, 41 Although previous studies have mainly focused on a direct pro-inflammatory pathway in TLR3 signaling, our data suggest that the RIP3-dependent necrotic pathway is also important in amplifying tissue inflammation and degeneration in these diseases.
Intracellular components such as proteins, nucleotides and organelles can act as DAMPs to stimulate immune response when they are released from dying or dead cells. HMGB1 is one of the most characterized DAMPs released from necrotic cells. 42 It was shown that HMGB1 mediates a late-phase inflammatory response and death in septic mice. 43, 44 The extracellular release of HMGB1 is substantially increased during retinal degeneration after retinal detachment, 45 as well as dsRNA-induced retinal injury. Besides HMGB1, Shichita et al. 46 recently reported that other DAMPs such as extracellular peroxiredoxin family proteins mediate postischemic inflammation in the brain. In other studies, it was shown that damaged mitochondria released from necrotic cells are critical for inflammatory responses to tissue injury. 47, 48 These findings suggest that several DAMPs may contribute to inflammatory amplification in tissue degeneration and that preventing necrosis, which is the source of multiple DAMPs, may be a potential therapy to protect tissues against injury and excessive inflammation.
In conclusion, our data showed that RIP kinase mediates necrosis of the RPE and photoreceptors in dsRNA-induced retinal degeneration. Blockade of the RIP kinase pathway prevents the DAMP release from dying cells and dampens retinal inflammation, suggesting that RIP kinase may be a potential target for retinal degenerative diseases associated with inflammation.
Materials and methods Animals. All animal experiments adhered to the statement of the Association for Research in Vision and Ophthalmology, and the protocols were approved by the Animal Care Committee of Massachusetts Eye and Ear Infirmary. Rip3 À / À mice were provided by Dr. Vishva M. Dixit (Genentech, San Francisco, CA, USA) and backcrossed to C57BL/6 mice. 29 Age-matched WT C57BL/6 mice were purchased from the Jackson Laboratories (Bar Harbor, ME, USA). Mice were fed standard laboratory chow and allowed free access to water in an air-conditioned room with a 12-h light/12-h dark cycle.
Subretinal injection. Mice were anesthetized with intraperitoneal injection of 100 mg/kg ketamine and 10 mg/kg xylazine. Pupils were dilated and a sclerotomy was created B1 mm posterior to the limbus in the nasal hemisphere with a 30-gauge needle. A Glaser subretinal injector (20-gauge shaft with a 32-gauge tip; BD Biosciences, San Diego, CA, USA) connected to a syringe filled with poly(I : C) solution (1 mg/ml in PBS; Enzo, Farmingdale, NY, USA) was introduced into the subretinal space, and 2 ml of solution was injected. Successful administration was confirmed by the creation of retinal detachment of approximately one-half of the retina. As a control, PBS was injected using the same procedure. For treatment with inhibitors or antagonists, poly(I : C) solution was mixed with Z-VAD (Enzo), Nec-1 (Sigma, Saint Louis, MI, USA) or Box A (HMGBiotech, Milano, Italy) with the final concentration of 300 mM, 400 mM and 10 mg/ml, respectively. The doses of the compounds and recombinants were selected based on previous reports. 20, 49 Eyes that sustained marked surgical trauma (for example, retinal or subretinal hemorrhage, bacterial infection) were excluded from further analyses.
Cell culture. RPE cells were prepared as previously described with minor modifications. 50 The RPE-choroid-sclera complex of C57BL/6 or age-matched Rip3 À / À mice was separated and incubated in 0.2% Trypsin (Life Technologies, Grand Island, NY, USA) for 1 h at 37 1C in a 5% CO 2 atmosphere. The eyecups were transferred to DMEM medium (Life Technologies), and RPE sheets were scraped off with a forcep. The RPE sheets were triturated to form a single-cell suspension, resuspended in DMEM medium containing 10% FBS (Life Technologies) and seeded into 35-mm dishes. The RPE cells between passages 3 and 6 were plated into 96-or 12 wells at 2 Â 10 4 cells/cm 2 and were used for experiments.
Peritoneal macrophages were obtained from C57BL/6 or age-matched Rip3
À / À mice 3 days after an intraperitoneal injection of 3 ml 4% thioglycollate (BD Biosciences) as previously described. 51 The cells collected from the peritoneal cavity were resuspended in RPMI medium (Life Technologies) containing 10% FBS, and seeded into 12 wells at 1 Â 10 5 cells/cm 2 . Plates were washed twice, 6 h after seeding, and the adherent macrophages were used directly for the experiments.
Viability assay. Twenty-four hours after poly(I : C) (5 mg/ml) or TNF-a (30 ng/ml; R&D Systems, Minneapolis, MN, USA) stimulation, the cell viability was assessed using a modified MTT assay (Cell Counting Kit-8; Dojindo Laboratories, Kumamoto, Japan). Treatment with Z-VAD (30 mM) or Nec-1 (30 mM) was performed 1 h before poly(I : C) or TNF-a stimulation. This assay is based on the cleavage of 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) to formazan dye by the mitochondrial dehydrogenase enzyme. After incubation with WST-8 for 2 h at 37 1C, the absorbance was measured at 450 nm using a microplate leader.
Stimulation of macrophages with the supernatants from RPE cells. WT or Rip3
À / À RPE cells were treated with PBS, poly(I : C) (5 mg/ml) or poly(I:C) plus Z-VAD (30 mM). Three hours after stimulation, the culture medium was washed three times to remove poly(I : C) and replaced by fresh medium. After incubation for 24 h, the cellular supernatants were added to untreated WT macrophages. The amount of pro-inflammatory cytokines in the macrophage culture medium was measured using ELISA 24 h after treatment with the RPE supernatants.
RNA Extraction, RT-PCR and Quantitative Real-Time PCR. The posterior eyecups of mice containing the neuroretina, RPE/choroid and sclera Programmed necrosis: a key mediator of cell loss and DAMP-mediated inflammation Y Murakami et al were minced with scissors in lysis buffer (QIAGEN, Valencia, CA, USA). Total RNA extraction and reverse transcription were performed as previously reported. 20 A real-time PCR assay was performed with Prism 7700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). TaqMan Gene Expression assays were used to check the expression of RIP3 (Mm00444947_m1). For relative comparison of each gene, we analyzed the Ct value of real-time PCR data with the DDCt method normalizing by an endogenous control (b-actin; Mm00607939_s1).
Western Blotting. The posterior eyecups of mice or cells were collected and lysed in lysis buffer (50 mM Tris-HCl (pH 8), 120 mM NaCl and 1% NP-40, supplemented with a mixture of protein inhibitors (Roche Diagnostics, Basel, Switzerland)). Samples were run on 4-12% SDS-polyacrylamide gel electrophoresis and transferred onto PVDF membrane. After blocking with blocking buffer (Thermo Scientific, Rockford, IL, USA), the membrane was reacted with RIP3 (1 : 10 000; Sigma) or p-NF-kB (1 : 1000; Cell Signaling, Danvers, MA, USA) antibody. Membranes were then developed with enhanced chemiluminescence. Lane-loading differences were normalized by b-actin (1 : 1000; Cell Signaling).
Histological Examination. Mouse eyes were enucleated and frozen in OCT compound (Sakura Finetechnical Co., Tokyo, Japan). Sections (1-mm thick) were prepared along the horizontal meridian and subsequently stained with hematoxylin and eosin. Five sections were randomly selected from each eye. The mid-peripheral retina in the poly(I : C)-injected area (800 mm from the optic nerve in the nasal hemisphere) was photographed, and the ONL thickness was measured at 10 points in each section and averaged. The tissue samples were assigned numbers and letters, and the observers were masked from the conditions. Flatmount staining. Eyes were enucleated and fixed in 4% PFA for 1 h. After washing with PBS, the anterior segment and the neuroretina were removed under a microscope. The RPE-choroid-sclera complex was blocked with 10% non-fat dried milk and 0.3% triton X in PBS for 1 h and was incubated with Alexa Fluor 594-conjugated Zo-1 antibody (1 : 100; Life Technologies) at 4 1C overnight. Five areas in poly(I : C)-injected areas were randomly photographed at Â 40 magnification with a Leica SP2 confocal microscopy, and the number of RPE cells were counted using ImageJ 1.43u software and averaged.
Immunofluorescence. Cryosections were incubated with anti-CD11b antibody (1 : 100; BD Biosciences) or anti-cleaved caspase-3 (1 : 100; Cell Signaling) at 4 1C overnight. A nonimmune serum was used as a negative control. Alexa Fluor 594-conjugated antibodies (1 : 300; Life Technologies) were used as secondary antibodies. Immunofluorescence images were acquired with a Leica SP2 confocal microscope.
ELISA. The protein levels of TNF-a and IL-6 in the extracts from posterior eyecups were determined with ELISA kits for TNF-a (R&D Systems) and IL-6 (R&D Systems). For HMGB1 measurement, the mouse posterior eyecups were put into 100 ml PBS in a 96-well plate and then the vitreous humor was collected. Samples were centrifuged at 15 000 r.p.m. for 5 min, and the supernatants were subjected to HMGB1 ELISA (Shinotest Corporation, Tokyo, Japan) according to the manufacturer's instructions.
TEM. The eyes were enucleated, and the posterior segments were fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M cacodylate buffer with 0.08 M CaCl 2 at 4 1C. The sections of posterior eyecups were postfixed for 1.5 h in 2% aqueous OsO 4 , dehydrated in ethanol and water, and embedded in EPON. Ultrathin sections were cut from blocks and stained with saturated aqueous uranyl acetate and Sato's lead stain. The specimens were observed with Philips CM10 electron microscope (Boston, MA, USA).
Statistical analysis. Statistical differences between two groups were analyzed using the Mann-Whitney U-test. Multiple group comparison was performed by ANOVA followed by Tukey-Kramer adjustments. Differences were considered significant at Po0.05.
